4
Changes in Ownership
Inhibitor Therapeutics, Inc. Filed Acc 0001360218-06-000012
Director sold 12,000 shares at an average $2.56 ($30,660)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X02/primary_doc.xml…